The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
Clinical trial NCT05492643 · UNKNOWN
Trial details
- NCT number
- NCT05492643
- Sponsor
- Zhongnan Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-13
- Primary completion
- 2023-02-27
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.